1996
DOI: 10.1007/bf02093597
|View full text |Cite
|
Sign up to set email alerts
|

Acute mediastinal pancreatic fluid collection with pericardial and pleural effusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…The diagnosis should be made promptly, as suggested by current guidelines, by transthoracic echocardiography; this might be difficult in patients with mechanical ventilation;6 initial treatment remains the rapid resolution of haemodynamic deterioration by pericardiocentesis (class IA) 7. Pericardiocentesis should be performed in all patients with haemodynamic impairment demonstrated with clinical and echocardiographic signs such as pulsus paradoxus, Beck’s triad and transmitral flow variability >25% in pulsed Doppler; in addition to pericardiocentesis, there have been some case reports of patients treated with somatostatin8 or its analogue, octreotide acetate, especially in patients with chronic effusions 9. It should be noted that these novel medical treatments should never replace pericardiocentesis and have only been used as adjunctive therapy.…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis should be made promptly, as suggested by current guidelines, by transthoracic echocardiography; this might be difficult in patients with mechanical ventilation;6 initial treatment remains the rapid resolution of haemodynamic deterioration by pericardiocentesis (class IA) 7. Pericardiocentesis should be performed in all patients with haemodynamic impairment demonstrated with clinical and echocardiographic signs such as pulsus paradoxus, Beck’s triad and transmitral flow variability >25% in pulsed Doppler; in addition to pericardiocentesis, there have been some case reports of patients treated with somatostatin8 or its analogue, octreotide acetate, especially in patients with chronic effusions 9. It should be noted that these novel medical treatments should never replace pericardiocentesis and have only been used as adjunctive therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the CTSI having been successfully used to predict overall mortality in patients with AP, Balthazar and others have confirmed that when using the CTSI there was no significant difference in mortality between patients who have 30–50% necrosis and patients who have more than 50% necrosis [7], [26]. Recent publications have confirmed that the mediastinal acute fluid collection in patients with AP can result in increased morbidity and mortality [27]. Furthermore, as a risk factor for severe AP, pleural effusion was included in the RCSI scoring system [28].…”
Section: Discussionmentioning
confidence: 99%
“…Also, the extension of proteolytic enzymes through the esophageal hiatus into the posterior mediastinum, in close proximity to the heart, the esophagus, and vital vascular structures, significantly increases the potential for life-threatening complications such as penetration of the pericardium or compression of the left atrium and ventricle resulting in a right ventricular pressure gradient [14]. …”
Section: Discussionmentioning
confidence: 99%